Leerink Partnrs has cut its Q3 2025 earnings estimate for Regeneron Pharmaceuticals, citing lowered expectations across the ...

Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% compared with the industry’s rise of 0.4%. The stock has also outperformed the ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

Vontobel Holding Ltd. increased its stake in Regeneron Pharmaceuticals by 13.6% in the first quarter, signaling bullish ...

REGN Regeneron Pharmaceuticals, Inc. Stock Price & Overview Analyze With AI Follow 72.7K followers $537.04 2.13 (+0.40%) 9:37 AM 07/02/25 ...

The franchise drug for autoimmune disorders such as dermatitis could face a challenger: A candidate from Apogee Therapeutics.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Regeneron Pharmaceuticals, Inc.

This was the stock's second consecutive day of losses.

Check out the latest Regeneron Pharmaceuticals Inc. (REGN) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Regeneron Pharmaceuticals, Inc. (REGN) on Wednesday announced that the U.S. Food and Drug Administration has granted accelerated approval for its Lynozyfic to treat adult patients with relapsed or ...